Skip to content

Using Virtual Reality for Patients With Gastrointestinal Disease

Using Virtual Reality to Foster Engagement, Understanding, and Knowledge in Patients With Gastrointestinal Disease and Their Families

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03719209
Enrollment
200
Registered
2018-10-25
Start date
2017-09-01
Completion date
2019-10-31
Last updated
2019-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Disease, Inflammatory Bowel Diseases

Keywords

Crohns disease, Patient Education, Ulcerative Colitis, Celiac, Ulcer, Polyp, Gastrointestinal bleeding, Inflammatory Bowel Disease, Virtual Reality

Brief summary

The primary aim of this study is to evaluate the effect and impact of a technology which creates a virtual reality (VR), personalized representation of a patient's endoscopic findings in comparison our standard practice (SP). Our study will compare the level of knowledge, understanding and satisfaction the patient and family have between those receiving SP and those receiving both SP and VR.

Interventions

OTHERHealthVoyager

HealthVoyager is a virtual reality application that allows providers to create customized representations for patients and share the results of endoscopic procedures via an interactive platform. The app can show both normal and abnormal endoscopic findings and anatomy. Families will also receive a web link so that they may access the procedure results via the app at home on their smartphone or tablet.

Patients and families will receive handouts with printed images of their endoscopic findings, as per standard practice at Boston Children's Hospital.

Sponsors

Klick Health
CollaboratorUNKNOWN
Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 8-25 years of age who are willing and able to participate * Patients who recently had an endoscopic procedure at Boston Children's Hospital

Exclusion criteria

* Patients who are unable to provide consent due to age or developmental status

Design outcomes

Primary

MeasureTime frameDescription
Patient and family knowledge, understanding, and satisfaction1 monthOur study will measure the levels of patient and family engagement using a survey designed specifically for the study. The survey is at a roughly 3rd grade reading level and includes approximately 10 questions with answers on a Likert scale. The internally designed survey will specifically measure patient and family opinions on learning about the results of their procedure, as well as objective anatomical knowledge. The minimum score for each question is a 1, designating Strongly disagree. The maximum score for each question is a 10, designating Strongly agree. Thus, higher scores represent better outcomes.

Secondary

MeasureTime frameDescription
Longitudinal Medication Adherenceup to 5 yearsMedication Adherence will be assessed via retrospective chart review and medication refill data.
Longitudinal Readmission Rateup to 5 yearsReadmission rates will be measured via retrospective chart review and hospital admission data.
Patient Satisfaction Scale1 monthThe Patient Satisfaction Scale (Hojat et al., 2011) will be used to measure patient satisfaction. The Patient Satisfaction Scale is a validated survey with 10 questions. Respondents can answer 1 through 7 for each question. 1 represents Strongly Disagree while 7 represents Strongly Agree. Higher score represent better outcomes in this scale.
Client Satisfaction Questionnaire1 monthThe Client Satisfaction Questionnaire (Larsen et al., 1979) will measure client satisfaction. The questionnaire has 8 questions with 4 possible answers for each question. A 4 represents the best possible outcome; a 1 represents the worst possible outcome.

Countries

United States

Contacts

Primary ContactMcKenzie Leier, BA
mckenzie.leier@childrens.harvard.edu6179194609

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026